ACSS2 and cancer: Intriguingly, we show that in contrast to fibroblasts (4), cancer cells lacking both ACLY and ACSS2 [double knockout (DKO) cells] are viable, proliferate, contain a nuclear-cytosolic pool of acetyl-CoA, and sustain protein acetylation.